Abstract
Monodispersed microparticles with a poly(d,l-lactide-co-glycolide) (PLGA) core and a poly(ethyl 2-cyanoacrylate) (PE2CA) shell were prepared by Shirasu porous glass (SPG) membrane emulsification to reduce the initial burst release of doxorubicin (DOX). Solution mixtures with different weight ratios of PLGA polymer and E2CA monomer were permeated under pressure through an SPG membrane with 1.9 ώm pore size into a continuous water phase with sodium lauryl sulfate as a surfactant. Core-shell structured microparticles were formed by the mechanism of anionic interfacial polymerization of E2CA and precipitation of both polymers. The average diameter of the resulting microparticles with various PLGA:E2CA ratios ranged from 1.42 to 2.73 ώm. The morphology and core-shell structure of the microparticles were observed by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The DOX release profiles revealed that the microparticles with an equivalent PLGA:E2CA weight ratio of 1:1 exhibited the optimal condition to reduce the initial burst of DOX. The initial release rate of DOX was dependent on the PLGA:E2CA ratio, and was minimized at a 1:1 ratio.
Similar content being viewed by others
References
R. Bodmeier and J. W. McGinity,Pharm. Res.,4, 465 (1987).
K. Juni, J. Ogata, M. Nakano, T. Ichihara, K. Mori, and M. Akagi,Chem. Pharm. Bull.,33, 313 (1985).
J. M. Ruiz, B. Tissier, and J. P. Benoit,Int. J. Pharm.,49, 69 (1989).
R. Bodmeier and H. Chen,J. Pharm. Pharmacol.,40, 754 (1988).
D. L. Wise, G. J. McCormick, G. P. Willet, and L. C. Anderson,Life Sci.,19, 867 (1976).
K. A. Athanasiou, G. G. Niederauer, and C. M. Agrawal,Biomaterials,17, 93 (1996).
R. Jalil and J. R. Nixon,J. Microencap.,7, 297 (1990).
H. Okada, M. Miyamoto, T. Heya, Y. Inoue, S. Kamei, Y. Ogawa, and H. Taguchi,J. Control. Release,28, 121 (1994).
M. O. Omelczuk and J. W. McGinity,Pharm. Res.,9, 26 (1992).
S. S. Shah, Y. Cha, and C. G. Pitt,J. Control. Release,38, 261 (1992).
K. J. Pekarek, J. S. Jacob, and E. Mathiowitz,Mater. Res. Soc. Symp. Proc.,331, 97 (1994).
A. Kishida, K. Murakami, H. Goto, M. Akashi, H. Kubita, and T. Endo,J. Bioact. Compat. Polym.,13, 270 (1998).
K. Shiga, N. Muramatsu, and T. Kondo,J. Pharm. Pharmacol.,48, 891 (2002).
L. Y. Chu, S. H. Park, T. Yamaguchi, and S. I. Nakao,Langmuir,18, 1856 (2002).
C. Y. Huang and Y. D. Lee,Int. J. Pharm.,325, 132 (2006).
S. Gibaud, C. Rousseau, C. Weingarten, R. Favier, L. Douay, J. Andreux, and P. Couvreur,J. Control. Release,52, 131 (1998).
W. R. Vezin and A. T. Florence,J. Biomed. Mater. Res.,14, 93 (1980).
F. Leonard, R. K. Kulkarni, G. Brandes, J.Nelson, and J. J. Cameron,J. Appl. Polym. Sci.,10, 259 (1966).
R. H. Müller, C. Lherm, J. Herbort, T. Blunk, and P. Couvreur,Int. J. Pharm.,84, 1 (1992).
V. Lenaerts, P. Couvreur, D. Christiaens-Leyh, E. Joiris, M. Roland, B. Rollman, and P. Speiser,Biomaterials,5, 65 (1984).
D. Scherer, J. R. Robinson, and J. Kreuter,Int. J. Pharm.,101, 165 (1994).
C. O’Sullivan and C. Birkinshaw,Polym. Degrad. Stabil.,78, 7 (2002).
M. E. Page-Clisson, H. Pinto-Alphandary, M. Ourevitch, A. Andremont, and P. Couvreur,J. Control. Release,56, 23 (1998).
C. O’Sullivan and C. Birkinshaw,Biomaterials,25, 4375 (2004).
L. Y. Chu, R. Xie, J. H. Zhu, W. M. Chen, T. Yamaguchi, and S. I. Nakao,J. Colloid Interf. Sci.,265, 187 (2003).
N. Behan, C. Birkinshaw, and N. Clarke,Biomaterials,22, 1335 (2001).
S. Omi, T. Senba, M. Nagai, and G.-H. Ma,J. Appl. Polym. Sci.,79, 2200 (2001).
S. W. Choi, H. Y. Kwon, W. S. Kim, and J. H. Kim,Colloid Surface A,201, 283 (2002).
J. Brandrup, E. H. Immergut, and E. A. Grulke,Polymer Handbook, 4th edition, Vol. 1, p. 708.
B. S. Zolnik and D. J. Burgess,J. Control. Release,122, 338 (2007).
A. Bootz, T. Russ, F. Gores, M. Karas, and J. Kreuter,Eur. J. Pharm. Biopharm.,60, 391 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, SH., Baek, HH., Kim, J.H. et al. Core-shell poly(d,l-lactide-co-glycolide)/poly(ethyl 2-cyanoacrylate) microparticles with doxorubicin to reduce initial burst release. Macromol. Res. 17, 1010–1014 (2009). https://doi.org/10.1007/BF03218649
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03218649